Subscribe To Our Free Newsletter |
Biocon inks pact with Medix to commercialize weight mgmt product
Biocon said that it has signed semi-exclusive distribution and supply agreement with Medix for the commercialization of its vertically integrated drug product, Liraglutide (gSaxenda), used in the treatment of chronic weight management.